Search
for
Sort by
Research 181–210 of 727
- DNA Methylation‐Regulated ZDHHC17 Promotes the Risk of Facial Skin Aging
- Australasian Society for Dermatology Research Meeting, May 2006
- Registrars’ Symposium: Summaries of Papers
- Abstracts Pt.30
- Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7
- Use of chemotherapy during human pregnancy
- REPORTS: Summary of the Recommendations on Sexual Dysfunctions in Women
- Weakly supervised learning of biomedical information extraction from curated data
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
- Telogen Effluvium
- Epigenetic control of adult stem cell function
- Relationship Between Androgen Levels and Blood Pressure in Young Women With Polycystic Ovary Syndrome
- Lichen Planopilaris: Update on Diagnosis and Treatment
- Drug-Induced Hair Loss and Hair Growth
- The reliability of horizontally sectioned scalp biopsies in the diagnosis of chronic diffuse telogen hair loss in women
- Eclipta alba extract with potential for hair growth promoting activity
- Drug-Induced Skin, Nail and Hair Disorders
- Principles of Hair Cycle Control
- Cryptic Patterning of Avian Skin Confers a Developmental Facility for Loss of Neck Feathering
- Dermatologic manifestations of endocrine disorders
- Genome-wide association study identifies a new locus JMJD1C at 10q21 that may influence serum androgen levels in men
- Adverse effects of common medications on male fertility
- Androgens and Female Sexual Function and Dysfunction—Findings From the Fourth International Consultation of Sexual Medicine
- MENSTRUAL DISORDERS IN ADOLESCENTS
- Safety of dermatologic medications in pregnancy and lactation
- Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation
- Frontal fibrosing alopecia: treatment with oral dutasteride and topical pimecrolimus
- Management of congenital ichthyoses: European guidelines of care, part two
- How should postmenopausal androgen excess be evaluated?
- DRUG‐ASSOCIATED ALOPECIA